View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088
Open access

A szomatosztatin az emésztőrendszerre sokrétűen hat. Gátolja az emésztőrendszeri hormonok felszabadulását, a gyomor, a hasnyálmirigy és az epe exokrin működését, csökkenti a motilitást és befolyásolja egyes tápanyagok felszívódását is. E sokirányú hatás alapján fokozott várakozás előzte meg a szomatosztatinkezelés eredményességét különböző emésztőrendszeri betegségekben. A szomatosztatinkezelés realitását az elhúzódó hatású analógok (octreotid, lanreotid) kialakítása teremtette meg. Az elmúlt negyed században kiterjedt vizsgálatok tisztázták a szomatosztatinanalógok eredményességét és helyét különböző emésztőrendszeri betegségek kezelésében. A tanulmány az eredmények rövid összefoglalására és értékelésére tesz kísérletet. A kezelés az emésztőrendszer számos kóros állapotában hatékony, a klinikai gyakorlat részévé azonban csak a neuroendokrin daganatok elsődleges konzervatív, valamint a nyelőcsővisszér-vérzések és a hasnyálmirigysipolyok kiegészítő kezelésében vált. Orv. Hetil., 2013, 154, 1535–1540.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Brazeau, P., Vale, W., Burgus, R., et al.: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science, 1973, 179, 77–79.

    Burgus R. , 'Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone ' (1973 ) 179 Science : 77 -79.

    • Search Google Scholar
  • Burgus, R., Ling, N., Butcher, M., et al.: Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc. Natl. Acad. Sci. USA, 1973, 70, 684–688.

    Butcher M. , 'Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone ' (1973 ) 70 Proc. Natl. Acad. Sci. USA : 684 -688.

    • Search Google Scholar
  • Pradayrol, J., Chayvialle, J. A., Carlguist, M., et al.: Isolation of a porcine intestinal peptide with C-terminal somatostatin. Biochem. Biophys. Res. Commun., 1978, 85, 701–708.

    Carlguist M. , 'Isolation of a porcine intestinal peptide with C-terminal somatostatin ' (1978 ) 85 Biochem. Biophys. Res. Commun. : 701 -708.

    • Search Google Scholar
  • Polak, J. M., Pearse, A. G., Grimelius, L., et al.: Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet, 1975, 1 (7918), 1220–1222.

    Grimelius L. , 'Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells ' (1975 ) 1 Lancet : 1220 -1222.

    • Search Google Scholar
  • Van Op den Bosch, J., Adriaensen, D., Van Nassauw, L., et al.: The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review. Regul. Pept., 2009, 156, 1–8.

    Nassauw L. , 'The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review ' (2009 ) 156 Regul. Pept. : 1 -8.

    • Search Google Scholar
  • Corleto, V. D., Severi, C., Romano, G., et al.: Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol. Motil., 2006, 18, 217–225.

    Romano G. , 'Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells ' (2006 ) 18 Neurogastroenterol. Motil. : 217 -225.

    • Search Google Scholar
  • Samson, W. K., Zhang, J. V., Avsian-Kretchmer, O., et al.: Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular and metabolic functions. J. Biol. Chem., 2008, 283, 31949–31959.

    Avsian-Kretchmer O. , 'Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular and metabolic functions ' (2008 ) 283 J. Biol. Chem. : 31949 -31959.

    • Search Google Scholar
  • Gong, A. Y., Tietz, P. S., Muff, M. A., et al.: Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes. Am. J. Physiol. Cell Physiol., 2003, 284, C1205–C1214.

    Muff M. A. , 'Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes ' (2003 ) 284 Am. J. Physiol. Cell Physiol. : C1205 -C1214.

    • Search Google Scholar
  • Lang, A., Sakhnini, E., Fidder, H. H., et al.: Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int., 2005, 25, 808–816.

    Fidder H. H. , 'Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells ' (2005 ) 25 Liver Int. : 808 -816.

    • Search Google Scholar
  • Gunshefski, L. A., Rifley, W. J., Slattery, D. W., et al.: Somatostatin stimulation of the normal esophagus. Am. J. Surg., 1992, 163, 59–62.

    Slattery D. W. , 'Somatostatin stimulation of the normal esophagus ' (1992 ) 163 Am. J. Surg. : 59 -62.

    • Search Google Scholar
  • Kravetz, D., Bosch, J., Terés, J., et al.: Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal haemorrhage. Hepatology, 1984, 4, 442–446.

    Terés J. , 'Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal haemorrhage ' (1984 ) 4 Hepatology : 442 -446.

    • Search Google Scholar
  • Walker, S., Stiehl, A., Raedsch, R., et al.: Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology, 1986, 6, 112–115.

    Raedsch R. , 'Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study ' (1986 ) 6 Hepatology : 112 -115.

    • Search Google Scholar
  • Lo, G. H., Perng, D. S., Chang, C. Y., et al.: Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding. J. Gastroenterol. Hepatol., 2013, 28, 684–689.

    Chang C. Y. , 'Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding ' (2013 ) 28 J. Gastroenterol. Hepatol. : 684 -689.

    • Search Google Scholar
  • Planas, R., Quer, J. C., Boix, J., et al.: A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology, 1994, 20, 370–375.

    Boix J. , 'A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding ' (1994 ) 20 Hepatology : 370 -375.

    • Search Google Scholar
  • Avgerinos, A., Armonis, A., Raptis, S.: Somatostatin or octreotide versus endoscopic sclerotherapy in acute variceal haemorrhage: a meta-analysis study. J. Hepatol., 1995, 22, 247–248.

    Raptis S. , 'Somatostatin or octreotide versus endoscopic sclerotherapy in acute variceal haemorrhage: a meta-analysis study ' (1995 ) 22 J. Hepatol. : 247 -248.

    • Search Google Scholar
  • Jenkins, S. A., Kingsnorth, A. N., Ellenbogen, S., et al.: Octreotide in the control of post-sclerotherapy bleeding from oesophageal varices, ulcers and oesophagitis. HPB Surgery, 1996, 10, 1–6.

    Ellenbogen S. , 'Octreotide in the control of post-sclerotherapy bleeding from oesophageal varices, ulcers and oesophagitis ' (1996 ) 10 HPB Surgery : 1 -6.

    • Search Google Scholar
  • Jenkins, S. A., Shields, R., Davies, M., et al.: A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut, 1997, 41, 526–533.

    Davies M. , 'A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage ' (1997 ) 41 Gut : 526 -533.

    • Search Google Scholar
  • D’Amico, G., Pietrosi, G., Tarantino, I., et al.: Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology, 2003, 124, 1277–1291.

    Tarantino I. , 'Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis ' (2003 ) 124 Gastroenterology : 1277 -1291.

    • Search Google Scholar
  • Choi, C. W., Kang, D. H., Kim, H. W., et al.: Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy. World J. Gastroenterol., 2011, 17, 3441–3447.

    Kim H. W. , 'Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy ' (2011 ) 17 World J. Gastroenterol. : 3441 -3447.

    • Search Google Scholar
  • Brown, C., Subramanian, V., Wilcox, C. M., et al.: Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies. Dig. Dis. Sci., 2010, 55, 2129–2134.

    Wilcox C. M. , 'Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies ' (2010 ) 55 Dig. Dis. Sci. : 2129 -2134.

    • Search Google Scholar
  • Bassi, C., Dervenis, C., Butturini, G., et al., for the International Study Group on Pancreatic Fistula Definition: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery, 2005, 138, 8–13.

    Butturini G. , 'Postoperative pancreatic fistula: an international study group (ISGPF) definition ' (2005 ) 138 Surgery : 8 -13.

    • Search Google Scholar
  • Li-Ling, J., Irving, M.: Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br. J. Surg., 2001, 88, 190–199.

    Irving M. , 'Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials ' (2001 ) 88 Br. J. Surg. : 190 -199.

    • Search Google Scholar
  • Bassi, C., Butturini, G., Molinari, F., et al.: Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig. Surg., 2004, 21, 54–59.

    Molinari F. , 'Pancreatic fistula rate after pancreatic resection. The importance of definitions ' (2004 ) 21 Dig. Surg. : 54 -59.

    • Search Google Scholar
  • Tulassay, Z., Flautner, L., Vadász, A., et al.: Short report: octreotide in the treatment of external pancreatic fistulas. Aliment. Pharmacol. Ther., 1993, 7, 323–325.

    Vadász A. , 'Short report: octreotide in the treatment of external pancreatic fistulas ' (1993 ) 7 Aliment. Pharmacol. Ther. : 323 -325.

    • Search Google Scholar
  • Tulassay, Z., Flautner, L., Fehérvári, I., et al.: Somatostatin in the prevention of postoperative increase of pancreatic enzyme after pancreatic surgery. [Somatostatin a hasnyálmirigy-műtétek után kialakuló pancreas-enzim emelkedés megelőzésében.] Orv. Hetil., 1992, 133, 777–780. [Hungarian]

    Fehérvári I. , 'Somatostatin in the prevention of postoperative increase of pancreatic enzyme after pancreatic surgery. [Somatostatin a hasnyálmirigy-műtétek után kialakuló pancreas-enzim emelkedés megelőzésében.] ' (1992 ) 133 Orv. Hetil. : 777 -780.

    • Search Google Scholar
  • Leandros, E., Antonakis, P. T., Albanopoulos, K., et al.: Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can. J. Gastroenterol., 2004, 18, 303–306.

    Albanopoulos K. , 'Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas ' (2004 ) 18 Can. J. Gastroenterol. : 303 -306.

    • Search Google Scholar
  • Gayral, F., Campion, J. P., Regimbeau, J. M., et al.: Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae. Ann. Surg., 2009, 250, 872–877.

    Regimbeau J. M. , 'Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae ' (2009 ) 250 Ann. Surg. : 872 -877.

    • Search Google Scholar
  • Zeng, Q., Zhang, Q., Han, S., et al.: Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Pancreas, 2008, 36, 18–25.

    Han S. , 'Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials ' (2008 ) 36 Pancreas : 18 -25.

    • Search Google Scholar
  • Ramos-De la Medina, A., Sarr, M. G.: Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection. J. Hepatobiliary Pancreat. Surg., 2006, 13, 190–193.

    Sarr M. G. , 'Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection ' (2006 ) 13 J. Hepatobiliary Pancreat. Surg. : 190 -193.

    • Search Google Scholar
  • Alghamdi, A. A., Jawas, A. M., Hart, R. S.: Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis. Can. J. Surg., 2007, 50, 459–466.

    Hart R. S. , 'Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis ' (2007 ) 50 Can. J. Surg. : 459 -466.

    • Search Google Scholar
  • Koti, R. S., Gurusamy, K. S., Fusai, G., et al.: Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review. HPB, 2010, 12, 155–165.

    Fusai G. , 'Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review ' (2010 ) 12 HPB : 155 -165.

    • Search Google Scholar
  • Coughlin, S., Roth, L., Lurati, G., et al.: Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis. World J. Surg., 2012, 36, 1016–1029.

    Lurati G. , 'Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis ' (2012 ) 36 World J. Surg. : 1016 -1029.

    • Search Google Scholar
  • Gans, S. L., van Westreenen, H. L., Kiewiet, J. J. S., et al.: Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula. Br. J. Surg., 2012, 99, 754–760.

    Kiewiet J. J. S. , 'Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula ' (2012 ) 99 Br. J. Surg. : 754 -760.

    • Search Google Scholar
  • Tack, J., Arts, J., Caenepeel, P., et al.: Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat. Rev. Gastroenterol. Hepatol., 2009, 6, 583–590.

    Caenepeel P. , 'Pathophysiology, diagnosis and management of postoperative dumping syndrome ' (2009 ) 6 Nat. Rev. Gastroenterol. Hepatol. : 583 -590.

    • Search Google Scholar
  • Tulassay, Z., Tulassay, T., Gupta, R., et al.: Long acting somatostatin analogue in dumping syndrome. Br. J. Surg., 1989, 76, 1294–1295.

    Gupta R. , 'Long acting somatostatin analogue in dumping syndrome ' (1989 ) 76 Br. J. Surg. : 1294 -1295.

    • Search Google Scholar
  • Didden, P., Penning, C., Masclee, A. A.: Octreotide therapy in dumping syndrome: analysis of long-term results. Aliment. Pharmacol. Ther., 2006, 24, 1367–1375.

    Masclee A. A. , 'Octreotide therapy in dumping syndrome: analysis of long-term results ' (2006 ) 24 Aliment. Pharmacol. Ther. : 1367 -1375.

    • Search Google Scholar
  • Arts, J., Caenepeel, P., Bisschops, R., et al.: Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping. Clin. Gastroenterol. Hepatol., 2009, 7, 432–437.

    Bisschops R. , 'Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping ' (2009 ) 7 Clin. Gastroenterol. Hepatol. : 432 -437.

    • Search Google Scholar
  • Perry, M. D., Sandle, G. I.: Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 297, G159–G167.

    Sandle G. I. , 'Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin ' (2009 ) 297 Am. J. Physiol. Gastrointest. Liver Physiol. : G159 -G167.

    • Search Google Scholar
  • Abbas, Z., Moid, I., Khan, A. H., et al.: Efficacy of octreotide in diarrhoea due to Vibrio cholera: a randomized, controlled trial. Ann. Trop. Med. Parasitol., 1996, 90, 507–513.

    Khan A. H. , 'Efficacy of octreotide in diarrhoea due to Vibrio cholera: a randomized, controlled trial ' (1996 ) 90 Ann. Trop. Med. Parasitol. : 507 -513.

    • Search Google Scholar
  • Chatterjee, S., De Man, J., Van Marck, E.: Somatostatin and intestinal schistosomiasis: therapeutic and neuropathological implications in host-parasite interactions. Trop. Med. Int. Health, 2001, 6, 1008–1015.

    Marck E. , 'Somatostatin and intestinal schistosomiasis: therapeutic and neuropathological implications in host-parasite interactions ' (2001 ) 6 Trop. Med. Int. Health : 1008 -1015.

    • Search Google Scholar
  • Pai, V., Porter, K., Ranalli, M.: Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease. Pediatr. Blood Cancer, 2001, 56, 45–49.

    Ranalli M. , 'Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease ' (2001 ) 56 Pediatr. Blood Cancer : 45 -49.

    • Search Google Scholar
  • Soudah, H. C., Hasler, W. L., Owyang, C.: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N. Engl. J. Med., 1991, 325, 1461–1467.

    Owyang C. , 'Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma ' (1991 ) 325 N. Engl. J. Med. : 1461 -1467.

    • Search Google Scholar
  • Kobayashi, T., Kobayashi, M., Naka, M., et al.: Response to octreotide of intestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis. Intern. Med., 1993, 32, 607–609.

    Naka M. , 'Response to octreotide of intestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis ' (1993 ) 32 Intern. Med. : 607 -609.

    • Search Google Scholar
  • Tulassay, Z., Kisfalvi, K., Papp, M.: The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats. Z. Gastroenterol., 1995, 33, 99–102.

    Papp M. , 'The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats ' (1995 ) 33 Z. Gastroenterol. : 99 -102.

    • Search Google Scholar
  • Tulassay, Z., Flautner, L., Sándor, Z., et al.: Perioperative use of somatostatin in pancreatic surgery. Acta Biomed. Ateneo Parmense, 1993, 64, 205–211.

    Sándor Z. , 'Perioperative use of somatostatin in pancreatic surgery ' (1993 ) 64 Acta Biomed. Ateneo Parmense : 205 -211.

    • Search Google Scholar
  • Tulassay, Z., Döbrönte, Z., Prónai, L., et al.: Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Aliment. Pharmacol. Ther., 1998, 12, 1109–1112.

    Prónai L. , 'Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography ' (1998 ) 12 Aliment. Pharmacol. Ther. : 1109 -1112.

    • Search Google Scholar
  • Li, Z. S., Pan, X., Zhang, W. J., et al.: Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial. Am. J. Gastroenterol., 2007, 102, 46–51.

    Zhang W. J. , 'Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial ' (2007 ) 102 Am. J. Gastroenterol. : 46 -51.

    • Search Google Scholar
  • Herszényi, L., Tulassay, Z.: Octreotide in the prevention of post-ERCP pancreatic injury. Am. J. Gastroenterol., 2007, 102, 1539–1540.

    Tulassay Z. , 'Octreotide in the prevention of post-ERCP pancreatic injury ' (2007 ) 102 Am. J. Gastroenterol. : 1539 -1540.

    • Search Google Scholar
  • Omata, F., Deshpande, G., Tokuda, Y., et al.: Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. J. Gastroenterol., 2010, 45, 885–895.

    Tokuda Y. , 'Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis ' (2010 ) 45 J. Gastroenterol. : 885 -895.

    • Search Google Scholar